• Accelerating TB vaccine Research & Development through partnership
  • TBVI TBVI TBVI
    • Home
    • About us
      • TBVI at a glance
      • Mission
      • Organisation
        • Governance Board
        • Advisory Committee
        • Steering Committee
        • Operational Office
        • Product and Clinical Development Team
        • Portfolio Management Committee
      • TBVI consortium
      • Key achievements and impact
      • Financials
    • What we do
      • Pipeline of vaccines
      • Research & Development
      • Services
    • How we work
      • Business model
      • Partnership
    • For partners
      • For researchers and vaccine developers
        • Partners pages
        • Become a TBVI partner
        • Access to services
        • Conferences, meetings and workshops
      • TBVAC2020
        • Word from the chair
        • TBVAC2020 project overview and achievements
        • TBVAC2020 project members
        • TBVAC2020 scientific publications
        • TBVAC2020 other publications
      • MTBVAC in Newborns
        • MTBVAC in newborns
        • Coordinator and partners
        • News and Publications
        • Communication tools
      • For funders
        • TBVI R&D priorities and funding opportunities
        • TBVI service provision and funding opportunities
        • Why invest in TBVI
    • News
    • Contact us:

    Governance Board

    Home / About us / Organisation / Governance Board
    • Dr H. Onno Ruding (chairman)
      Dr H. Onno Ruding (chairman)Chairman of CEPS, Retired Vice Chairman of Citibank, Former Dutch Minister of Finance, The Hague, The Netherlands
      • Prof. Sander van Deventer
        Prof. Sander van DeventerFounder and managing partner of Forbion Capital Partners Professor in Translational Gastroenterology at the University of Leiden The Netherlands
        • Dr Michel Goldman
          Dr Michel GoldmanFull Professor at Université Libre de Bruxelles, Formerly IMI Executive Director Brussels, Belgium
          • Prof. Paul-Henri Lambert
            Prof. Paul-Henri LambertDirector International Advanced Course of Vaccinology University of Geneva Geneva, Switzerland
            • Anna Koivuniemi
              Anna KoivuniemiPartner, McKinsey & Company, Amsterdam, the Netherlands
              • Prof. Michel Kazatchkine, MD
                Prof. Michel Kazatchkine, MDSenior Fellow, Global Health Programme, Graduate Institute of International and Development Studies
                • Prof. Dr Dr h.c. Stefan H.E. Kaufmann
                  Prof. Dr Dr h.c. Stefan H.E. KaufmannFounding Director Max-Planck-Institute for Infection Biology Berlin, Germany (GB from June 2019)
                  • Vytenis Povilas Andriukaitis 
                    Vytenis Povilas Andriukaitis Outstanding Lithuanian politician, EU Commissioner for Health and Food Safety (2014-2019).
                    Menu
                    • Home
                    • About us
                    • What we do
                    • How we work
                    • For researchers and vaccine developers
                    • For funders
                    • Pipeline of vaccines
                    • News
                    TuBerculosis Vaccine Initiative (TBVI)

                    Runderweg 6
                    8219 PK Lelystad
                    The Netherlands
                    Email: info@tbvi.eu
                    Phone: +31 320 277 550

                    © 2015 TuBerculosis Vaccine Initiative (TBVI) | ALL RIGHTS RESERVED | Disclaimer | Sitemap | Door Internetbureau Redkiwi

                    Start typing and press Enter to search

                    Cookies

                    This website uses cookies that help the website function

                    OK No